• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在心血管稳态和疾病中的众多重要作用。

The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.

作者信息

Neppl Ronald L, Wang Da-Zhi

机构信息

Boston Children's Hospital, Department of Cardiology ; Harvard Medical School, Department of Pediatrics Boston MA, 02115.

出版信息

Genes Dis. 2014 Mar 1;1(1):18-39. doi: 10.1016/j.gendis.2014.06.003.

DOI:10.1016/j.gendis.2014.06.003
PMID:25328909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4200483/
Abstract

According to the World Health Organization, cardiovascular disease accounts for approximately 30% of all deaths in the United States, and is the worldwide leading cause of morbidity and mortality. Over the last several years, microRNAs have emerged as critical regulators of physiological homeostasis in multiple organ systems, including the cardiovascular system. The focus of this review is to provide an overview of the current state of knowledge of the molecular mechanisms contributing to the multiple causes of cardiovascular disease with respect to regulation by microRNAs. A major challenge in understanding the roles of microRNAs in the pathophysiology of cardiovascular disease is that cardiovascular disease may arise from perturbations in intracellular signaling in multiple cell types including vascular smooth muscle and endothelial cells, cardiac myocytes and fibroblasts, as well as hepatocytes, pancreatic β-cells, and others. Additionally, perturbations in intracellular signaling cascades may also have profound effects on heterocellular communication via secreted cytokines and growth factors. There has been much progress in recent years to identify the microRNAs that are both dysregulated under pathological conditions, as well as the signaling pathway(s) regulated by an individual microRNA. The goal of this review is to summarize what is currently known about the mechanisms whereby microRNAs maintain cardiovascular homeostasis and to attempt to identify some key unresolved questions that require further study.

摘要

根据世界卫生组织的数据,心血管疾病约占美国所有死亡人数的30%,并且是全球发病和死亡的主要原因。在过去几年中,微小RNA已成为包括心血管系统在内的多个器官系统中生理稳态的关键调节因子。本综述的重点是概述微小RNA调控在导致心血管疾病多种病因的分子机制方面的当前知识状态。理解微小RNA在心血管疾病病理生理学中作用的一个主要挑战是,心血管疾病可能源于多种细胞类型(包括血管平滑肌和内皮细胞、心肌细胞和成纤维细胞,以及肝细胞、胰腺β细胞等)细胞内信号传导的紊乱。此外,细胞内信号级联反应的紊乱也可能通过分泌的细胞因子和生长因子对异细胞通讯产生深远影响。近年来,在确定病理条件下失调的微小RNA以及单个微小RNA调控的信号通路方面取得了很大进展。本综述的目的是总结目前已知的微小RNA维持心血管稳态的机制,并试图确定一些需要进一步研究的关键未解决问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639c/6150065/38d7545f5842/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639c/6150065/8a052e8b9971/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639c/6150065/38d7545f5842/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639c/6150065/8a052e8b9971/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/639c/6150065/38d7545f5842/gr2.jpg

相似文献

1
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.微小RNA在心血管稳态和疾病中的众多重要作用。
Genes Dis. 2014 Mar 1;1(1):18-39. doi: 10.1016/j.gendis.2014.06.003.
2
Role of miR-181 family in regulating vascular inflammation and immunity.miR-181 家族在调节血管炎症和免疫中的作用。
Trends Cardiovasc Med. 2014 Apr;24(3):105-12. doi: 10.1016/j.tcm.2013.09.002. Epub 2013 Nov 1.
3
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
4
Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling.通过影响转化生长因子-β家族信号传导来控制血管(功能障碍)功能的调控RNA。
EXCLI J. 2015 Jul 10;14:832-50. doi: 10.17179/excli2015-423. eCollection 2015.
5
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.发育和疾病中血管平滑肌细胞分化的分子调控
Physiol Rev. 2004 Jul;84(3):767-801. doi: 10.1152/physrev.00041.2003.
6
Small Molecules with Big Impacts on Cardiovascular Diseases.小分子对心血管疾病的重大影响。
Biochem Genet. 2020 Jun;58(3):359-383. doi: 10.1007/s10528-020-09948-z. Epub 2020 Jan 29.
7
An emerging role for the miR-26 family in cardiovascular disease.微小RNA-26家族在心血管疾病中的新作用。
Trends Cardiovasc Med. 2014 Aug;24(6):241-8. doi: 10.1016/j.tcm.2014.06.003. Epub 2014 Jun 12.
8
Vascular microRNAs.血管 microRNAs。
Curr Drug Targets. 2010 Aug;11(8):943-9. doi: 10.2174/138945010791591313.
9
Functions of the bone morphogenetic protein signaling pathway through microRNAs (review).骨形态发生蛋白信号通路通过微小RNA的功能(综述)
Int J Mol Med. 2015 Mar;35(3):563-8. doi: 10.3892/ijmm.2015.2060. Epub 2015 Jan 2.
10
Cardiac fibroblast physiology and pathology.心肌成纤维细胞的生理学和病理学。
Compr Physiol. 2015 Apr;5(2):887-909. doi: 10.1002/cphy.c140053.

引用本文的文献

1
Increased Levels of hsa-miR-199a-3p and hsa-miR-382-5p in Maternal and Neonatal Blood Plasma in the Case of Placenta Accreta Spectrum.胎盘植入谱系病例中母血和新生儿血浆中hsa-miR-199a-3p和hsa-miR-382-5p水平升高
Int J Mol Sci. 2024 Dec 11;25(24):13309. doi: 10.3390/ijms252413309.
2
Long non-coding RNAs in cardiac hypertrophy and heart failure: functions, mechanisms and clinical prospects.长链非编码 RNA 在心肌肥厚和心力衰竭中的作用、机制及临床前景。
Nat Rev Cardiol. 2024 May;21(5):326-345. doi: 10.1038/s41569-023-00952-5. Epub 2023 Nov 20.
3
Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome.

本文引用的文献

1
Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study.血液微小RNA谱与血清脂质水平以及与葡萄糖代谢和胰岛素抵抗相关的代谢物相关,并确定了代谢综合征潜在的途径:年轻芬兰人心血管风险研究
Mol Cell Endocrinol. 2014 Jun 25;391(1-2):41-9. doi: 10.1016/j.mce.2014.04.013. Epub 2014 Apr 28.
2
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.心脏成纤维细胞来源的富含微小 RNA 过客链的外泌体介导心肌细胞肥大。
J Clin Invest. 2014 May;124(5):2136-46. doi: 10.1172/JCI70577. Epub 2014 Apr 17.
3
甲状腺激素与免疫反应、炎症及非甲状腺疾病综合征的相互作用
Front Cell Dev Biol. 2021 Jan 21;8:614030. doi: 10.3389/fcell.2020.614030. eCollection 2020.
4
Comparison Between the Diagnostic Performance of 1.5 T and 3.0 T field Strengths for Detecting Deep Vein Thrombosis Using Magnetic Resonance Black-Blood Thrombus Imaging.1.5T 与 3.0T 场强磁共振黑血血栓成像诊断深静脉血栓的效能比较。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620921235. doi: 10.1177/1076029620921235.
5
Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells.Wnt 信号通路介导 miR-133a 的核重新定位,从而在心脏细胞中转录调控 Dnmt3b。
Sci Rep. 2019 Jun 27;9(1):9320. doi: 10.1038/s41598-019-45818-4.
6
The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application.外泌体源性生物标志物在动脉粥样硬化中的研究进展及其临床应用。
J Cardiovasc Transl Res. 2019 Feb;12(1):68-74. doi: 10.1007/s12265-018-9796-y. Epub 2018 May 25.
7
How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.心肌细胞如何感知导致心脏重塑的病理生理应激。
Cell Mol Life Sci. 2017 Mar;74(6):983-1000. doi: 10.1007/s00018-016-2373-0. Epub 2016 Oct 6.
8
Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease.非酒精性脂肪性肝病和冠状动脉疾病患者的循环微小RNA
BMJ Open Gastroenterol. 2016 Jul 26;3(1):e000096. doi: 10.1136/bmjgast-2016-000096. eCollection 2016.
9
Experimental procedures to identify and validate specific mRNA targets of miRNAs.用于鉴定和验证微小RNA(miRNA)特定信使核糖核酸(mRNA)靶标的实验程序。
EXCLI J. 2015 Jul 2;14:758-90. doi: 10.17179/excli2015-319. eCollection 2015.
10
miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy.miR-410和miR-495在多种心肌病中受到动态调控,抑制它们可减轻病理性肥大。
PLoS One. 2016 Mar 21;11(3):e0151515. doi: 10.1371/journal.pone.0151515. eCollection 2016.
Inhibition of miR-25 improves cardiac contractility in the failing heart.
抑制 miR-25 可改善心力衰竭心脏的收缩功能。
Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12.
4
Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.miR-155 的缺失可保护心脏免受病理性心肌肥厚的影响。
Circ Res. 2014 May 9;114(10):1585-95. doi: 10.1161/CIRCRESAHA.114.303784. Epub 2014 Mar 21.
5
Heart failure.心力衰竭。
JACC Heart Fail. 2013 Feb;1(1):1-20. doi: 10.1016/j.jchf.2012.10.002. Epub 2013 Feb 4.
6
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.高密度脂蛋白转运的微小RNA-223调节内皮细胞中细胞间黏附分子-1的表达。
Nat Commun. 2014 Feb 28;5:3292. doi: 10.1038/ncomms4292.
7
Targeting the pancreatic β-cell to treat diabetes.针对胰岛β细胞治疗糖尿病。
Nat Rev Drug Discov. 2014 Apr;13(4):278-89. doi: 10.1038/nrd4231. Epub 2014 Feb 14.
8
Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction.急性非ST段抬高型心肌梗死后老年患者循环miR-499-5p的入院水平与死亡风险
Int J Cardiol. 2014 Mar 15;172(2):e276-8. doi: 10.1016/j.ijcard.2013.12.203. Epub 2014 Jan 8.
9
What we talk about when we talk about fat.我们谈论脂肪时在谈论什么。
Cell. 2014 Jan 16;156(1-2):20-44. doi: 10.1016/j.cell.2013.12.012.
10
TNFα-induced miR-130 resulted in adipocyte dysfunction during obesity-related inflammation.TNFα 诱导的 miR-130 导致肥胖相关炎症期间脂肪细胞功能障碍。
FEBS Lett. 2013 Nov 29;587(23):3853-8.